Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up, Journal of the American Academy of Dermatology, vol.74, issue.4, pp.700-708 ,
DOI : 10.1016/j.jaad.2015.11.030
Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy, Arthritis & Rheumatism, vol.8, issue.9, pp.3044-3056, 2007. ,
DOI : 10.4049/jimmunol.165.10.5558
Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo, Journal of Experimental Medicine, vol.182, issue.4, pp.1169-1174, 1995. ,
DOI : 10.1084/jem.182.4.1169
2013 Long-Term Remissions of Severe Pemphigus after Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response, Science Translational Medicine, vol.5, issue.175, pp.175-205 ,
Identification of a Potential Effector Function for IgE Autoantibodies in the Organ-Specific Autoimmune Disease Bullous Pemphigoid, Journal of Investigative Dermatology, vol.120, issue.5, pp.784-788, 2003. ,
DOI : 10.1046/j.1523-1747.2003.12146.x
Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils, European Journal of Immunology, vol.260, issue.7, pp.2152-2158, 1998. ,
DOI : 10.1002/(SICI)1521-4141(199807)28:07<2152::AID-IMMU2152>3.0.CO;2-G
Mechanisms for Decreased Function of B Cells in Aged Mice and Humans, The Journal of Immunology, vol.180, issue.5, pp.2741-2746, 1950. ,
DOI : 10.4049/jimmunol.180.5.2741
Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients, Journal of Investigative Dermatology, vol.133, issue.12, pp.2786-2788 ,
DOI : 10.1038/jid.2013.236
2016 Changes in Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor Isotypes Serum Levels in Patients with Rheumatoid Arthritis Following Treatment with Different Biological Drugs, Clinical and Experimental Rheumatology, vol.34, issue.3, pp.424-429 ,
Incidence of bullous pemphigoid and pemphigus vulgaris, BMJ, vol.337, issue.jul09 1, p.209, 2008. ,
DOI : 10.1136/bmj.a209
A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid, New England Journal of Medicine, vol.346, issue.5, pp.321-327 ,
DOI : 10.1056/NEJMoa011592
2011 [Pemphigus. Guidelines for the diagnosis and treatment, pp.252-258 ,
Rituximab for Treatment-Refractory Pemphigus and Pemphigoid: A Case Series, p.17, 2011. ,
Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study, BMJ, vol.337, issue.jul09 1, p.180, 2008. ,
DOI : 10.1136/bmj.a180
Sang-Cheol Bae, and Gwan Gyu Song 2011 The Efficacy and Safety of Rituximab for the Treatment of Active Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Rheumatology International, issue.11, pp.31-1493 ,
Selection of the B-Cell Repertoire and B-Cell Development, Effect of Age on Humoral Immunity Immunological Reviews, vol.160, pp.115-126, 1997. ,
Human IgG1 Monoclonal Antibody against Human Collagen 17 Noncollagenous 16A Domain Induces Blisters via Complement Activation in Experimental Bullous Pemphigoid Model, The Journal of Immunology, vol.185, issue.12, pp.185-7746, 1950. ,
DOI : 10.4049/jimmunol.1000667
Molecular Mapping of a Pathogenically Relevant BP180 Epitope Associated with Experimentally Induced Murine Bullous Pemphigoid, Journal of Immunology, issue.11, pp.155-5449, 1950. ,
Cytokine-producing B lymphocytes?key regulators of immunity, Current Opinion in Immunology, vol.20, issue.3, pp.332-338, 2008. ,
DOI : 10.1016/j.coi.2008.03.003
B cells participate in tolerance and autoimmunity through cytokine production, Autoimmunity, vol.45, issue.1, pp.1-12 ,
DOI : 10.3109/08916934.2012.665527
Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity, Journal of Clinical Investigation, vol.122, issue.4, pp.1393-1402 ,
DOI : 10.1172/JCI58743DS1
Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination, Journal of Neuroimmunology, vol.290, pp.49-53 ,
DOI : 10.1016/j.jneuroim.2015.11.006
B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses, Journal of Investigative Dermatology, vol.128, issue.12, pp.2859-2869, 2008. ,
DOI : 10.1038/jid.2008.178
Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response, Arthritis Research & Therapy, vol.11, issue.4, p.131, 2009. ,
DOI : 10.1186/ar2798
Therapy in Patients with Rheumatoid Arthritis: Predictors of Response and B Cell Subset Regeneration after Repeated Treatment, Arthritis and Rheumatism, vol.58, issue.6, pp.1566-1575 ,
Enzyme-Linked Immunosorbent Assay for the Combination of Bullous Pemphigoid Antigens 1 and 2 in the Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.147, issue.3, pp.293-298, 2011. ,
DOI : 10.1001/archdermatol.2011.21
Enno, and Detlef Zillikens 2011 Diagnosis and Treatment of Patients with Autoimmune Bullous Disorders in Germany, Dermatologic Clinics, vol.29, issue.4, pp.663-671 ,
Zillikens 2000 Serum Levels of Autoantibodies to BP180 Correlate with Disease Activity in Patients with Bullous Pemphigoid, Archives of Dermatology, vol.136, issue.2, pp.174-178 ,
Razzaque Ahmed 2013 Treatment of Bullous Pemphigoid with Rituximab: Critical Analysis of the Current Literature, Journal of Drugs in Dermatology: JDD, vol.12, issue.6, pp.672-677 ,
Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity, Journal of Clinical Investigation, vol.120, issue.11, pp.4111-4117 ,
DOI : 10.1172/JCI44425
Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies, Journal of Investigative Dermatology, vol.109, issue.4, pp.573-579, 1997. ,
DOI : 10.1111/1523-1747.ep12337492
Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up, Journal of the American Academy of Dermatology, vol.74, issue.4, pp.700-708 ,
DOI : 10.1016/j.jaad.2015.11.030
The future of anti-CD20 monoclonal antibodies: are we making progress?, Blood, vol.117, issue.11, pp.2993-3001, 2011. ,
DOI : 10.1182/blood-2010-07-298356
B cell development and receptor diversity during aging, Current Opinion in Immunology, vol.17, issue.5, pp.463-467, 2005. ,
DOI : 10.1016/j.coi.2005.07.002
The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile, Journal of the American Academy of Dermatology, vol.40, issue.2, pp.167-170, 1999. ,
DOI : 10.1016/S0190-9622(99)70183-0
CD35) Transcript and Its Correlation with the Clinical Disease Activity in Rheumatoid Arthritis Patients, Leucocyte Complement Receptor Clinical and Experimental Immunology, vol.1, issue.1763, pp.327-335, 2014. ,
Paraneoplastic Pemphigus, New England Journal of Medicine, vol.323, issue.25, pp.1729-1735, 1990. ,
DOI : 10.1056/NEJM199012203232503
Defining the Role of Complement in Experimental Pemphigus Vulgaris in Mice, Journal of Immunology, vol.137, issue.9, pp.2835-2840, 1950. ,
Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy, Arthritis & Rheumatism, vol.8, issue.9, pp.3044-3056, 2007. ,
DOI : 10.4049/jimmunol.165.10.5558
The balance between IL-1 and IL-1Ra in disease, Cytokine & Growth Factor Reviews, vol.13, issue.4-5, pp.4-5, 2002. ,
DOI : 10.1016/S1359-6101(02)00020-5
Relationship of leukocyte CR1 transcript and protein with the pathophysiology and prognosis of systemic lupus erythematosus: A follow-up study, Lupus, vol.151, issue.10, pp.1010-1018, 2011. ,
DOI : 10.1038/ni1113
??-MSH-Stimulated Tolerogenic Dendritic Cells Induce Functional Regulatory T Cells and Ameliorate Ongoing Skin Inflammation, Journal of Investigative Dermatology, vol.132, issue.7, pp.1814-1824 ,
DOI : 10.1038/jid.2012.59
URL : http://doi.org/10.1038/jid.2012.59
Vesicular and Bullous Disorders: Pemphigus, Dermatologic Clinics, vol.25, issue.4, pp.597-603, 2007. ,
DOI : 10.1016/j.det.2007.07.001
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients, Immunity, vol.32, issue.1, pp.129-140, 2010. ,
DOI : 10.1016/j.immuni.2009.11.009
Transcriptional basis of lymphocyte tolerance, Immunological Reviews, vol.272, issue.1, pp.105-119, 2006. ,
DOI : 10.1016/S1074-7613(01)00085-1
IL-10 produced by activated human B cells regulates CD4+ T-cell activation in vitro, European Journal of Immunology, vol.40, issue.10, pp.2686-2691, 2010. ,
DOI : 10.1002/eji.200940288
The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis, Arthritis Research & Therapy, vol.10, issue.4, p.212, 2008. ,
DOI : 10.1186/ar2457
Mice Lacking Endogenous IL-10-Producing Regulatory B Cells Develop Exacerbated Disease and Present with an Increased Frequency of Th1/Th17 but a Decrease in Regulatory T Cells, The Journal of Immunology, vol.186, issue.10, pp.186-5569, 1950. ,
DOI : 10.4049/jimmunol.1100284
APRIL levels are associated with disease activity in human chronic graft-versus-host disease, Haematologica, vol.101, issue.7, pp.312-315 ,
DOI : 10.3324/haematol.2016.145409
2014 Shared VH1-46 Gene Usage by Pemphigus Vulgaris Autoantibodies Indicates Common Humoral Immune Responses among Patients, Nature Communications, vol.5, p.4167 ,
DOI : 10.1038/ncomms5167
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120239
Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo, Journal of Experimental Medicine, vol.182, issue.4, pp.1169-1174, 1995. ,
DOI : 10.1084/jem.182.4.1169
2013 Long-Term Remissions of Severe Pemphigus after Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response, Science Translational Medicine, vol.5, issue.175, pp.175-205 ,
Dennis 2001 Negative Regulation of T-Cell Activation and Autoimmunity by Mgat5 N-Glycosylation, Nature, vol.409, issue.6821, pp.733-739 ,
DOI : 10.1038/35055582
From desk to bed: Computational simulations provide indication for rheumatoid arthritis clinical trials, BMC Systems Biology, vol.7, issue.1, p.10, 2013. ,
DOI : 10.1186/1752-0509-7-10
Identification of a Potential Effector Function for IgE Autoantibodies in the Organ-Specific Autoimmune Disease Bullous Pemphigoid, The Journal of Investigative Dermatology, vol.120, issue.5, pp.784-788, 2003. ,
Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice, Journal of Clinical Investigation, vol.121, issue.9, pp.3645-3656, 2011. ,
DOI : 10.1172/JCI46274DS1
Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils, European Journal of Immunology, vol.260, issue.7, pp.2152-2158, 1998. ,
DOI : 10.1002/(SICI)1521-4141(199807)28:07<2152::AID-IMMU2152>3.0.CO;2-G
Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions, Molecular Immunology, vol.46, issue.14, pp.2767-2773, 2009. ,
DOI : 10.1016/j.molimm.2009.05.181
Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis, The Journal of Immunology, vol.178, issue.12, pp.7868-7878, 1950. ,
DOI : 10.4049/jimmunol.178.12.7868
A Pathogenic Role for IgE in Autoimmunity: Bullous Pemphigoid IgE Reproduces the Early Phase of Lesion Development in Human Skin Grafted to nu/nu Mice, Journal of Investigative Dermatology, vol.127, issue.11, pp.2605-2611, 2007. ,
DOI : 10.1038/sj.jid.5700958
Mapping the Binding Sites of Anti-BP180 Immunoglobulin E Autoantibodies in Bullous Pemphigoid, Journal of Investigative Dermatology, vol.125, issue.3, pp.467-472, 2005. ,
DOI : 10.1111/j.0022-202X.2005.23853.x
B cells regulate autoimmunity by provision of IL-10, Nature Immunology, vol.3, issue.10, pp.944-950, 2002. ,
DOI : 10.1038/ni833
Mechanisms for Decreased Function of B Cells in Aged Mice and Humans, The Journal of Immunology, vol.180, issue.5, pp.2741-2746, 1950. ,
DOI : 10.4049/jimmunol.180.5.2741
Functional role of the KCa3.1 potassium channel in synovial fibroblasts from rheumatoid arthritis patients, Journal of Cellular Physiology, vol.3, issue.7, pp.1677-1688 ,
DOI : 10.1186/ar142
Receptor editing: an approach by autoreactive B cells to escape tolerance, Journal of Experimental Medicine, vol.177, issue.4, pp.999-1008, 1993. ,
DOI : 10.1084/jem.177.4.999
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190958/pdf
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice, Nature, vol.334, issue.6184, pp.676-682, 1988. ,
DOI : 10.1038/334676a0
Rituximab for the Treatment of Non-Hodgkin?s Lymphoma and Chronic Lymphocytic Leukaemia, Drugs, vol.27, issue.8, pp.261-272, 2010. ,
DOI : 10.1016/S0140-6736(96)91681-5
Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients, Journal of Investigative Dermatology, vol.133, issue.12, pp.2786-2788 ,
DOI : 10.1038/jid.2013.236
The Role of ThPOK in Control of CD4/CD8 Lineage Commitment, Annual Review of Immunology, vol.28, issue.1, pp.295-320 ,
DOI : 10.1146/annurev.immunol.25.022106.141715
Bullous Pemphigoid IgG Induces BP180 Internalization via?a Macropinocytic Pathway, The American Journal of Pathology, vol.182, issue.3, pp.828-840 ,
DOI : 10.1016/j.ajpath.2012.11.029
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590760
2016 Changes in Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor Isotypes Serum Levels in Patients with Rheumatoid Arthritis Following Treatment with Different Biological Drugs, Clinical and Experimental Rheumatology, vol.34, issue.3, pp.424-429 ,
Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis, Journal of Neurology, vol.4, issue.7, pp.1115-1119 ,
DOI : 10.3389/fimmu.2013.00494
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, vol.117, issue.2, pp.530-541, 2011. ,
DOI : 10.1182/blood-2010-07-294249
Immunological tolerance: Danger ?? pathogen on the premises!, Danger -Pathogen on the Premises! Immunological Tolerance, pp.519-522, 1996. ,
DOI : 10.1016/S0960-9822(02)00531-6
Incidence of bullous pemphigoid and pemphigus vulgaris, BMJ, vol.337, issue.jul09 1, p.209, 2008. ,
DOI : 10.1136/bmj.a209
Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immu !, pp.252-258 ,
Zajac 2015 T Cell Exhaustion during Persistent Viral Infections, Virology, pp.479-480 ,
Rituximab for Treatment-Refractory Pemphigus and Pemphigoid: A Case Series, p.17, 2011. ,
DOI : 10.1016/j.jaad.2010.07.032
B-cell suppression of delayed hypersensitivity reactions, Nature, vol.248, issue.5475, pp.550-551 ,
DOI : 10.1159/000229624
PD-1 and Its Ligands in Tolerance and Immunity, Annual Review of Immunology, vol.26, issue.1, pp.677-704, 2008. ,
DOI : 10.1146/annurev.immunol.26.021607.090331
Human leukocyte antigens class I and class II in patients with pemphigus in southern Turkey, International Journal of Dermatology, vol.15, issue.1, pp.53-58 ,
DOI : 10.1006/jaut.2000.0388
Targeted Disruption of the Pemphigus Vulgaris Antigen (Desmoglein 3) Gene in Mice Causes Loss of Keratinocyte Cell Adhesion with a Phenotype Similar to Pemphigus Vulgaris, The Journal of Cell Biology, vol.12, issue.5, pp.1091-1102, 1997. ,
DOI : 10.1128/MCB.14.4.2404
Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, vol.3, issue.5517, pp.495-497 ,
DOI : 10.1042/bj1280427
Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study, BMJ, vol.337, issue.jul09 1, p.180, 2008. ,
DOI : 10.1136/bmj.a180
IRF5-mediated signaling and implications for SLE, Clinical Immunology, vol.153, issue.2, pp.343-352 ,
DOI : 10.1016/j.clim.2014.06.001
Isenberg 2005 B-Cell Depletion in the Treatment of Patients with Systemic Lupus Erythematosus: A Longitudinal Analysis of 24 Patients, Rheumatology, issue.12, pp.44-1542 ,
Sang-Cheol Bae, and Gwan Gyu Song 2011 The Efficacy and Safety of Rituximab for the Treatment of Active Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Rheumatology International, issue.11, pp.31-1493 ,
Selection of the B-Cell Repertoire and B-Cell Development, Effect of Age on Humoral Immunity Immunological Reviews, vol.160, pp.115-126, 1997. ,
The CD20 Calcium Channel Is Localized to Microvilli and Constitutively Associated with Membrane Rafts, Journal of Biological Chemistry, vol.27, issue.19, pp.19893-19901, 2004. ,
DOI : 10.1083/jcb.121.5.1121
Human Regulatory B Cells Combine Phenotypic and Genetic Hallmarks with a Distinct Differentiation Fate, The Journal of Immunology, vol.193, issue.5, pp.2258-2266, 1950. ,
DOI : 10.4049/jimmunol.1303214
Human IgG1 Monoclonal Antibody against Human Collagen 17 Noncollagenous 16A Domain Induces Blisters via Complement Activation in Experimental Bullous Pemphigoid Model, The Journal of Immunology, vol.185, issue.12, pp.185-7746, 1950. ,
DOI : 10.4049/jimmunol.1000667
Molecular Mapping of a Pathogenically Relevant BP180 Epitope Associated with Experimentally Induced Murine Bullous Pemphigoid, Journal of Immunology, issue.11, pp.155-5449, 1950. ,
Cytokine-producing B lymphocytes???key regulators of immunity, Current Opinion in Immunology, vol.20, issue.3, pp.332-338, 2008. ,
DOI : 10.1016/j.coi.2008.03.003
B cells participate in tolerance and autoimmunity through cytokine production, Autoimmunity, vol.45, issue.1, pp.1-12 ,
DOI : 10.3109/08916934.2012.665527
Regulatory B10 cell development and function: Fig. 1., International Immunology, vol.27, issue.10, pp.471-477 ,
DOI : 10.1093/intimm/dxv046
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817073
Blockade of Ca2+-activated K+ channels in T cells: an option for the treatment of multiple sclerosis?, European Journal of Immunology, vol.23, issue.4, pp.1023-1026, 2005. ,
DOI : 10.4049/jimmunol.166.2.936
CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease, Blood, vol.125, issue.11, pp.1830-1839 ,
DOI : 10.1182/blood-2014-09-599159
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation, Immunity, vol.41, issue.6, pp.1040-1051 ,
DOI : 10.1016/j.immuni.2014.10.016
URL : http://doi.org/10.1016/j.immuni.2014.10.016
Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity, Journal of Clinical Investigation, vol.122, issue.4, pp.1393-1402 ,
DOI : 10.1172/JCI58743DS1
Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination, Journal of Neuroimmunology, vol.290, pp.49-53 ,
DOI : 10.1016/j.jneuroim.2015.11.006
FcR-Independent Effects of IgE and IgG Autoantibodies in Bullous Pemphigoid, Journal of Immunology, vol.187, issue.1, pp.553-560, 1950. ,
Neonatal pemphigus vulgaris: role of passively transferred pemphigus antibodies, British Journal of Dermatology, vol.42, issue.4, pp.465-467, 1982. ,
DOI : 10.1159/000230636
Mediated N-Glycosylation Negatively Regulates Th1 Cytokine Production by T Cells, Journal of Immunology, vol.173, issue.12, pp.7200-7208, 1950. ,
B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses, Journal of Investigative Dermatology, vol.128, issue.12, pp.2859-2869, 2008. ,
DOI : 10.1038/jid.2008.178
Mechanisms maintaining peripheral tolerance, Nature Immunology, vol.6, issue.1, pp.21-27 ,
DOI : 10.4049/jimmunol.167.10.5636
Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response, Arthritis Research & Therapy, vol.11, issue.4, p.131, 2009. ,
DOI : 10.1186/ar2798
Role of different pathways of the complement cascade in experimental bullous pemphigoid, Journal of Clinical Investigation, vol.116, issue.11, pp.2892-2900, 2006. ,
DOI : 10.1172/JCI17891
Signaling via the MyD88 Adaptor Protein in B Cells Suppresses Protective Immunity during Salmonella typhimurium Infection, Signaling via the MyD88 Adaptor Protein in B Cells Suppresses Protective Immunity during Salmonella Typhimurium Infection, pp.777-790, 2010. ,
DOI : 10.1016/j.immuni.2010.10.016
LFA-3)-Mediated Adhesion in Human T Cells, MHC Class II Ligation Induces Experimental and Clinical Immunogenetics, vol.58, issue.152, pp.61-68, 1998. ,
Ectodomain Shedding Generates Neoepitopes on Collagen XVII, the Major Autoantigen for Bullous Pemphigoid, The Journal of Immunology, vol.185, issue.8, pp.185-4938, 1950. ,
DOI : 10.4049/jimmunol.1001524
Humanization of autoantigen, Nature Medicine, vol.280, issue.3, pp.378-383, 2007. ,
DOI : 10.1002/1099-1387(200008)6:8<378::AID-PSC265>3.0.CO;2-Q
Role for Lysosomal-Associated Protein Transmembrane 5 in the Negative Regulation of Surface B Cell Receptor Levels and B Cell Activation, Journal of Immunology, vol.185, issue.1, pp.294-301, 1950. ,
Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells, Nature Immunology, vol.163, issue.3, pp.257-264, 2010. ,
DOI : 10.1016/S0092-8674(00)80048-3
Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display, Journal of Clinical Investigation, vol.115, issue.4, pp.888-899, 2005. ,
DOI : 10.1172/JCI24185
Receptor Editing in a Transgenic Mouse Model: Site, Efficiency, and Role in B Cell Tolerance and Antibody Diversification, Immunity, vol.7, issue.6, pp.765-775, 1997. ,
DOI : 10.1016/S1074-7613(00)80395-7
Colocalization of the B Cell Receptor and CD20 Followed by Activation-Dependent Dissociation in Distinct Lipid Rafts, The Journal of Immunology, vol.169, issue.6, pp.2886-2891, 1950. ,
DOI : 10.4049/jimmunol.169.6.2886
2015 One Year in Review: The Pathogenesis of Rheumatoid Arthritis, Clinical and Experimental Rheumatology, vol.33, issue.4, pp.551-558 ,
CD20 Homo-oligomers Physically Associate with the B Cell Antigen Receptor, Journal of Biological Chemistry, vol.158, issue.27, pp.18545-18552 ,
DOI : 10.1002/eji.1830240406
New Classification Criteria for Systemic Sclerosis (Scleroderma) Rheumatic Diseases Clinics of, North America, vol.41, issue.3, pp.383-398, 2015. ,
Transcription Factor Zinc Finger and BTB Domain 1 Is Essential for Lymphocyte Development, The Journal of Immunology, vol.189, issue.3, pp.1253-1264, 1950. ,
DOI : 10.4049/jimmunol.1200623
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401355
Dissecting the Anti-Desmoglein Autoreactive B Cell Repertoire in Pemphigus Vulgaris Patients, The Journal of Immunology, vol.178, issue.9, pp.5982-5990, 1950. ,
DOI : 10.4049/jimmunol.178.9.5982
Genetics and novel aspects of therapies in systemic lupus erythematosus, Autoimmunity Reviews, vol.14, issue.11, pp.1005-1018 ,
DOI : 10.1016/j.autrev.2015.07.003
Monozygotic twins discordant for common variable immunodeficiency reveal impaired DNA demethylation during na?ve-to-memory B-cell transition, Nature Communications, vol.12, p.7335 ,
DOI : 10.1093/bioinformatics/btn615
Primary Gougerot-Sjogren syndrome: a dermatological approach, Journal of the European Academy of Dermatology and Venereology, vol.90, issue.3, pp.243-247 ,
DOI : 10.1007/BF00683877
Therapy in Patients with Rheumatoid Arthritis: Predictors of Response and B Cell Subset Regeneration after Repeated Treatment, Arthritis and Rheumatism, vol.58, issue.6, pp.1566-1575 ,
Enzyme-Linked Immunosorbent Assay for the Combination of Bullous Pemphigoid Antigens 1 and 2 in the Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.147, issue.3, pp.293-298, 2011. ,
DOI : 10.1001/archdermatol.2011.21
Dendritic Cell-Associated Lectin-1: A Novel Dendritic Cell-Associated, C-Type Lectin-Like Molecule Enhances T Cell Secretion of IL-4, The Journal of Immunology, vol.169, issue.10, pp.169-5638, 1950. ,
DOI : 10.4049/jimmunol.169.10.5638
Immunologic Self-Tolerance Maintained by Activated T Cells Expressing IL-2 Receptor Alpha-Chains (CD25) Breakdown of a Single Mechanism of Self-Tolerance Causes Various Autoimmune Diseases, Journal of Immunology, vol.155, issue.3, pp.1151-1164, 1950. ,
Production Of Epidermal Acantholysis In Normal Human Skin In Vitro By The Igg Fraction From Pemphigus Serum, Journal of Investigative Dermatology, vol.67, issue.2, pp.254-260, 1976. ,
DOI : 10.1111/1523-1747.ep12513454
Diagnosis and Treatment of Patients with Autoimmune Bullous Disorders in Germany, Dermatologic Clinics, vol.29, issue.4, pp.663-671 ,
DOI : 10.1016/j.det.2011.06.007
Zillikens 2000 Serum Levels of Autoantibodies to BP180 Correlate with Disease Activity in Patients with Bullous Pemphigoid, Archives of Dermatology, vol.136, issue.2, pp.174-178 ,
Autoantibodies to BP180 Associated with Bullous Pemphigoid Release Interleukin-6 and Interleukin-8 from Cultured Human Keratinocytes, The Journal of Investigative Dermatology, vol.115, issue.5, pp.842-848, 2000. ,
Dominant Autoimmune Epitopes Recognized by Pemphigus Antibodies Map to the N-Terminal Adhesive Region of Desmogleins, The Journal of Immunology, vol.167, issue.9, pp.5439-5448, 1950. ,
DOI : 10.4049/jimmunol.167.9.5439
Making sense of regulatory T cell suppressive function, Seminars in Immunology, vol.23, issue.4, pp.282-292, 2011. ,
DOI : 10.1016/j.smim.2011.04.003
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases, Nature, vol.42, issue.7492, pp.366-370 ,
DOI : 10.1002/eji.201142242
Razzaque Ahmed 2013 Treatment of Bullous Pemphigoid with Rituximab: Critical Analysis of the Current Literature, Journal of Drugs in Dermatology: JDD, vol.12, issue.6, pp.672-677 ,
Role for Cathepsin F in Invariant Chain Processing and Major Histocompatibility Complex Class II Peptide Loading by Macrophages, The Journal of Experimental Medicine, vol.161, issue.7, pp.1177-1186, 2000. ,
DOI : 10.1084/jem.188.4.725
Bullous pemphigoid in a patient with a C4 deficiency, British Journal of Dermatology, vol.52, issue.3, pp.296-298, 1991. ,
DOI : 10.1111/1523-1747.ep12283737
Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus, Human Molecular Genetics, vol.17, issue.6, pp.872-881, 2008. ,
DOI : 10.1093/hmg/ddm359
Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis, Arthritis & Rheumatism, vol.54, issue.7, pp.2202-2210, 2007. ,
DOI : 10.4049/jimmunol.173.4.2815
T Cell Activation, Annual Review of Immunology, vol.27, issue.1, pp.591-619, 2009. ,
DOI : 10.1146/annurev.immunol.021908.132706
The Crystal Structure of Human Cathepsin F and Its Implications for the Development of Novel Immunomodulators, Journal of Molecular Biology, vol.322, issue.3, pp.559-568, 2002. ,
DOI : 10.1016/S0022-2836(02)00780-5
T Cells in Rheumatoid Arthritis Is Genetically Determined by HLA Risk Alleles, The Journal of Immunology, vol.195, issue.3, pp.791-795, 1950. ,
DOI : 10.4049/jimmunol.1500267
B Lymphocytes Promote Expansion of Regulatory T Cells in Oral Tolerance: Powerful Induction by Antigen Coupled to Cholera Toxin B Subunit, Journal of Immunology, issue.12, pp.181-8278, 1950. ,
A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): Factors associated with B lymphocyte recovery, Clinical Immunology, vol.126, issue.3, pp.282-290, 2008. ,
DOI : 10.1016/j.clim.2007.11.012
A Single Helper T Cell Clone Is Sufficient to Commit Polyclonal Naive B Cells to Produce Pathogenic IgG in Experimental Pemphigus Vulgaris, The Journal of Immunology, vol.182, issue.3, pp.1740-1745, 1950. ,
DOI : 10.4049/jimmunol.182.3.1740
Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas, Characterization of New Human CD20 Monoclonal Antibodies with Potent Cytolytic Activity against Non-Hodgkin Lymphomas, pp.1793-1800, 2004. ,
DOI : 10.1182/blood-2004-01-0039
Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies, Annals of the Rheumatic Diseases, vol.68, issue.6, pp.1075-1077, 2009. ,
DOI : 10.1136/ard.2008.100438
Induction and stability of the anergic phenotype in T cells, Seminars in Immunology, vol.25, issue.4, pp.313-320 ,
DOI : 10.1016/j.smim.2013.10.010
Polymyositis in solid organ transplant recipients receiving tacrolimus, Journal of the Neurological Sciences, vol.345, issue.1-2, pp.239-243 ,
DOI : 10.1016/j.jns.2014.07.036
Induction of Cytosolic Calcium Flux by CD20 Is Dependent upon B Cell Antigen Receptor Signaling, Journal of Biological Chemistry, vol.169, issue.Suppl. 2, pp.16971-16984, 2008. ,
DOI : 10.4049/jimmunol.169.6.2886
Interleukin-35 induces regulatory B cells that suppress autoimmune disease, Interleukin-35 Induces Regulatory B Cells That Suppress Autoimmune Disease, pp.633-641, 2014. ,
DOI : 10.1074/jbc.M111.253500
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048323
New Insights into the Molecular Basis of T Cell Anergy: Anergy Factors, Avoidance Sensors, and Epigenetic Imprinting, The Journal of Immunology, vol.182, issue.12, pp.7331-7341, 1950. ,
DOI : 10.4049/jimmunol.0803917
Integrin ?v?8-Mediated TGF-? Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation, Immunity, vol.42, issue.5, pp.903-915 ,
DOI : 10.1016/j.immuni.2015.04.012
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell- Dependent Inflammatory Responses, Immunity, vol.28, issue.5, pp.639-650, 2008. ,
Zeng 2012 Association between HLA-DRB1 Polymorphisms and Pemphigus Vulgaris: A Meta-Analysis ,
Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis, British Journal of Dermatology, vol.162, issue.5, pp.1133-1137, 2011. ,
DOI : 10.1111/j.1365-2133.2009.09508.x
Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris, International Immunology, vol.23, issue.6, pp.365-373, 2011. ,
DOI : 10.1093/intimm/dxr020
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions, Nature, vol.3, issue.7423, pp.264-268 ,
DOI : 10.1038/ni833
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493692
Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies, Journal of Investigative Dermatology, vol.109, issue.4, pp.573-579, 1997. ,
DOI : 10.1111/1523-1747.ep12337492
Rituximab in High-Grade Lymphoma, Seminars in Hematology, vol.47, issue.2, pp.148-155 ,
DOI : 10.1053/j.seminhematol.2010.01.008